Glaucoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been definitively diagnosed with glaucoma, with no restrictions on age or gender
- People whose eye pressure is 21 mmHg or higher, even while taking the maximum amount of glaucoma medication that can be safely tolerated
- People whose eye pressure is below 21 mmHg but whose optic nerve damage from glaucoma has continued to get worse
Who may not be able to join:
- People who have other eye conditions that could affect eye pressure
- People who were taking steroid medications by mouth or injection (rather than eye drops) before the procedure
- People who have had another type of glaucoma surgery within the past 3 months
- People who had an eye infection within 2 weeks before the planned procedure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chengguo Zuo, M.D,Ph.D, Zhongshan Ophthalmic Center, Sun Yat-sen University
Phone: +8602066615461
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cytokine profiles(pg/ml); Intraocular pressure(mmHg); Anterior segment parameters(mm)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.